NSEUpdates23h ago · 30 Oct 2026, 04:59 pm
Updates
Paras Healthcare Limited · PARASHLTH
✦ AI SummaryPledge
Paras Healthcare Limited has informed the Exchange regarding 'Disclosure under Regulation 29(1) of SEBI (Substantial Acquisition of Shares and Takeovers) Regulations, 2011, as amended ( SEBI SAST Regulations )'. The company has received a disclosure from 360 ONE Special Opportunities Fund – Series 9 to 13 and 360 ONE Private Equity Fund- Series 2 and 360 ONE Equity Opportunity Fund- Series 4 regarding their acquisition of shares in the company.
Analysis Scores
Earnings Impact2/10
Growth Catalyst2/10
Governance Concern1/10
Regulatory Risk2/10
Balance Sheet Risk2/10
Liquidity Impact5/10
Market Sentiment5/10
✦ Ask a Question
Ask anything about this announcement — AI will answer based on the filing content.
Full Announcement
Paras Healthcare Limited has informed the Exchange regarding 'Disclosure under Regulation 29(1) of SEBI (Substantial Acquisition of Shares and Takeovers) Regulations, 2011, as amended ( SEBI SAST Regulations )'.
Attachments (1)
📄pdf
Download →
PARASHEALTH_30102026165908_Disclosure_-_Regulation_29_1__-_SAST_-_Final.pdf
View document text
Date: October 30, 2026
To, To,
National Stock Exchange of India Limited, BSE Limited,
Exchange Plaza, C-1, Block G, Phiroze Jeejeebhoy Towers,
Bandra Kurla Complex, Dalal Street, Mumbai – 400001
Bandra (E), Mumbai – 400051 BSE Scrip Code: 545005
NSE Scrip Symbol: PARASHLTH
Subject: Disclosure under Regulation 29(1) of SEBI (Substantial Acquisition of Shares
and Takeovers) Regulations, 2011, as amended (“SEBI SAST Regulations”)
Dear Sir/Madam,
Please find enclosed the disclosure received by the Company today, i.e., October 30, 2026, being
the Target Company under the SEBI SAST Regulations, from the below persons, being the
Acquirer under the SEBI SAST Regulations, along with the persons acting in concert (“PAC”) with
it, pursuant to Regulation 29(1) of the SEBI SAST Regulations.
Name(s) of the acquirer and Persons Acting in Concert (“PAC”) with the acquirer
360 ONE Special Opportunities Fund – Series 9
360 ONE Special Opportunities Fund – Series 10
360 ONE Special Opportunities Fund – Series 11
360 ONE Special Opportunities Fund – Series 12
360 ONE Special Opportunities Fund – Series 13
360 ONE Private Equity Fund- Series 2
360 ONE Equity Opportunity Fund- Series 4
This disclosure will also be hosted on the Company’s website at
https://www.parashospitals.com/investors.
You are requested to take the same on your record.
Thanking you.
For Paras Healthcare Limited
Rahul Kumar
Company Secretary and Compliance Officer
ICSI Membership No.: A20928
Encl.: As above
Format for Disclosures under Regulation 29(1) of SEBI (Substantial Acquisition
of Shares and Takeovers) Regulations, 2011
Part A- Details of the Acquisition
Name of the Target Company (TC) PARAS HEALTHCARE LIMITED
Name(s) of the acquirer and Persons Acting in
Scheme
Concert (PAC) with the acquirer
360 ONE Special Opportunities Fund Series 9
360 ONE Special Opportunities Fund- Series 10
360 ONE Special Opportunities Fund- Series 11
360 ONE Special Opportunities Fund- Series 12
360 ONE Special Opportunities Fund- Series 13
360 ONE Private Equity Fund- Series 2
360 ONE Equity Opportunity Fund- Series 4
Whether the acquirer belongs to No
Promoter/Promoter group
Name(s) of the Stock Exchange(s) where the BSE Limited
NSE Limited
shares of TC are Listed
Details of acquisition as follows Number % w.r.t. total % w.r.t.
share/ voting total diluted
capital share/ voting
wherever capital of
applicable (*) the TC (**)
Before the acquisition under consideration, 78,81,992 7.28% 7.28%
holding of acquirer along with PACs of:
a) Shares carrying voting rights
b) Shares in the nature of encumbrance
(pledge/ lien/ non-disposal undertaking/
others)
c) Voting rights (VR) otherwise than by
equity shares
d) Warrants/ convertible securities/ any
other instrument that entitles the
acquirer to receive shares carrying
voting rights in the TC (specify holding in
each category)
e) Total (a+b+c+d)
Details of acquisition Nil NA NA
a) Shares carrying voting rights acquired
b) VRs acquired otherwise than by equity
shares
c) Warrants/convertible securities/any
other instrument that entitles the
acquirer to receive shares carrying
voting rights in the TC (specify holding in
each category) acquired.
d) Shares in the nature of encumbrance
(pledge/ lien/ non-disposal undertaking/
others)
e) Total (a+b+c+/-d)
After acquisition, holding of acquirer along 78,81,992 7.28% 7.28%
with PACs of:
a) Shares carrying voting rights
b) Shares in the nature of encumbrance
(pledge/ lien/ non-disposal undertaking/
others) Shares pledged with the
acquirer.
c) VRs otherwise than by equity shares
d) Warrants/convertible securities/any
other instrument that entitles the
acquirer to receive shares carrying
voting rights in the TC (specify holding in
each category) after disposal
e) Total (a+b+c+d)
Mode of acquisition (e.g. open market/ public Unlisted shares conversion into listed shares on account
issue/ rights issue/ preferential allotment/ of an IPO
inter-se transfer, etc.)
Date of acquisition of shares VR/ warrants/ October 28, 2026 (listing date)
convertible securities/ any other instrument
that entitles the acquirer to receive shares in
the TC.
Equity share capital/ total voting capital of 10,82,01,194 Shares as per shareholder pattern as on
October 27, 2026 disclosed on BSE.
the TC before the said acquisition
Equity share capital/ total voting capital of 10,82,01,194 Shares as per shareholder pattern as on
October 27, 2026 disclosed on BSE.
the TC after the said acquisition
Total diluted share/ voting capital of the TC 10,85,00,790 Shares as per shareholder pattern as on
October 27, 2026 disclosed on BSE.
after the said acquisition
For 360 ONE Alternates Asset Management Limited For 360 ONE Asset Management Limited
(Investment Manager) (Investment Manager)
Vijay Shah Sonali Tendulkar
Compliance Officer Compliance Officer
Place: Mumbai
Date: October 30, 2026
Note:
(*) Total share capital/ voting capital to be taken as per the latest filing done by the company to the
Stock Exchange under Clause 35 of the listing Agreement for the listing date October 28, 2026.
(**) Diluted share/voting capital means the total number of shares in the TC assuming full conversion of
the outstanding convertible securities/warrants into equity shares of the TC.